Data are accessible from the dat\@OSU platform (<https://dataosu.obs-besancon.fr>) with the doi:[10.25666/DATAOSU-2019-01-25](https://doi.org/10.25666/DATAOSU-2019-01-25). Data are also available from Institute UTINAM at <http://perso.utinam.cnrs.fr/~lages/datasets/Wiki4Cancers/>.

Introduction {#sec001}
============

"Nearly every family in the world is touched by cancer, which is now responsible for almost one in six deaths globally" \[[@pone.0222508.ref001]\]. The number of new cancer cases in the world is steadily growing reaching 18.1 million projected for 2018 \[[@pone.0222508.ref002]\] with predicted new cases of 29.4 million for 2035 \[[@pone.0222508.ref003]\]. The detailed statistical analysis of new cases and mortality projected for 2018 is reported in \[[@pone.0222508.ref004]\]. Such statistical analysis is of primary importance for estimating the influence of cancer diseases on the world population. However, it requires significant efforts of research groups and medical teams all over the world such as consortia involved in the Global Burden of Diseases Study (GBD) \[[@pone.0222508.ref005]\] and the WHO GLOBOCAN reports \[[@pone.0222508.ref002]\].

Here we propose to probe the network of Wikipedia articles in order to infer specific interactions between cancer types and to measure world influence of cancers. Wikipedia can be seen as a global database of accumulated human knowledge with an immense variety of topics. Moreover the way Wikipedia articles are citing each other encodes scientific, social, historical, and many other aspects. In principle one should be able to extract from Wikipedia direct or indirect relations between cancers, drug cancers and countries. We focus our study on cancer which is one of the major cause of human mortality and which consequently have important social and political impacts all around the world. We aim to measure these impacts through the prism of Wikipedia.

Thus we develop a complementary approach to the existing statistical approaches \[[@pone.0222508.ref002], [@pone.0222508.ref004], [@pone.0222508.ref005]\], the Wikipedia network analysis based on the Google matrix and PageRank algorithm invented by Brin and Page in 1998 for World Wide Web search engine information retrieval \[[@pone.0222508.ref006], [@pone.0222508.ref007]\]. Applications of this approach to various directed networks are described at \[[@pone.0222508.ref008]\]. Here we use the network of English Wikipedia articles collected in May 2017 with *N* = 5 416 537 articles and connected by *N*~*l*~ = 122 232 032 directed links, i.e. quotations from one article to another.

At present Wikipedia represents a public, open, collectively created encyclopaedia with a huge amount of information exceeding those of Encyclopedia Britannica \[[@pone.0222508.ref009]\] in volume and accuracy of articles devoted to scientific topics \[[@pone.0222508.ref010]\]. As an example, articles on biomolecules are actively maintained by Wikipedians \[[@pone.0222508.ref011], [@pone.0222508.ref012]\]. The academic analysis of information collected in Wikipedia is growing, getting more tools and applications as reviewed in \[[@pone.0222508.ref013], [@pone.0222508.ref014]\]. The scientific analysis shows that the quality of Wikipedia articles is growing \[[@pone.0222508.ref015]\].

A new element of our analysis is the reduced Google matrix (REGOMAX) method developed recently \[[@pone.0222508.ref016], [@pone.0222508.ref017]\]. This method selects a modest size subset of *N*~*r*~ nodes of interest from a huge global directed network with *N* ≫ *N*~*r*~ nodes and generates the reduced Google matrix *G*~R~ taking into account all direct pathways and indirect pathways (i.e. those going through the global network) between the *N*~*r*~ nodes. This approach conserves the PageRank probabilities of nodes from the global Google matrix *G* (up to a normalization factor). This method uses the ideas coming from the scattering theory of complex nuclei, mesoscopic physics and quantum chaos.

The efficiency of this approach has been tested with Wikipedia networks of politicians \[[@pone.0222508.ref017]\], painters \[[@pone.0222508.ref018]\], world universities \[[@pone.0222508.ref019]\], with biological networks from SIGNOR data base \[[@pone.0222508.ref020]\], with world trade networks \[[@pone.0222508.ref021], [@pone.0222508.ref022]\], and with financial networks \[[@pone.0222508.ref023]\]. The method is general as it can be applied to any subset of nodes embedded in a huge directed network. The main outcome is a synthetic effective view of the subnetwork encoded by weighted links in the corresponding reduced Google matrix. The strength of the specific application of REGOMAX method to Wikipedia networks is the encyclopedic nature of Wikipedia. Myriads of subjects are treated in Wikipedia which allow through the network of articles to connect, at least indirectly, many very different topics such as, e.g., for the present study, countries and cancer types. Moreover in the framework of the REGOMAX method every articles in Wikipedia, even articles having apparently nothing to do with the subjects of interest possibly contribute to the effective link obtained between two chosen nodes (i.e., articles). Although the quality of Wikipedia articles is constantly growing \[[@pone.0222508.ref010]--[@pone.0222508.ref012], [@pone.0222508.ref015]\], the information extraction may be sensitive to noise coming from inadequate or not so relevant links introduced in certain Wikipedia articles. These noisy links, which depends on when the Wikipedia network has been extracted, usually are cleaned out by the Wikipedians collaborative effort. The lifetime before removal of these noisy links depend also on the subject. As there is no simple way to quantify this source of noise (the degree of relevance of a link between two articles), we assume that in average it causes no harm to the present study. The results are presented in the devoted section keeping in mind this limitation.

In this work the reduced network is composed of *N*~*cr*~ = 37 types of cancers listed at Wikipedia \[[@pone.0222508.ref024]\] and *N*~*d*~ = 203 drugs for cancer extracted from data base \[[@pone.0222508.ref025]\]. All these *N*~*cr*~ + *N*~*d*~ = 240 items had an active Wikipedia article in May 2017. All these cancers and drugs are listed in alphabetic order in Tables [1](#pone.0222508.t001){ref-type="table"} and [2](#pone.0222508.t002){ref-type="table"}. In addition we add to the selected set of articles *N*~*cn*~ = 195 world countries that allows us to analyze the global influence of cancer types (the ranking and REGOMAX analysis of countries are reported in \[[@pone.0222508.ref026], [@pone.0222508.ref027]\]). The PageRank list of the 195 selected countries is available at \[[@pone.0222508.ref028]\]. Thus in total the reduced Google matrix selected number of nodes is *N*~*r*~ = *N*~*cr*~ + *N*~*d*~ + *N*~*cn*~ = 435. The inclusion of these three groups (cancer types, cancer drugs, and countries) in the reduced set of *N*~*r*~ articles allows to investigate the interactions and influence of nodes inside group and between groups.

10.1371/journal.pone.0222508.t001

###### List of articles devoted to cancer types in May 2017 English Wikipedia.

This list of *N*~*cr*~ = 37 cancers taken from \[[@pone.0222508.ref024]\] is ordered by alphabetical order.

![](pone.0222508.t001){#pone.0222508.t001g}

       Cancer type                              Cancer type
  ---- ----------------------------------- ---- ----------------------
  1    Adrenal tumor                       21   Mesothelioma
  2    Anal cancer                         22   Multiple myeloma
  3    Appendix cancer                     23   Neuroendocrine tumor
  4    Bladder cancer                      24   Non-Hodgkin lymphoma
  5    Bone tumor                          25   Oral cancer
  6    Brain tumor                         26   Ovarian cancer
  7    Breast cancer                       27   Pancreatic cancer
  8    Cervical cancer                     28   Prostate cancer
  9    Cholangiocarcinoma                  29   Skin cancer
  10   Colorectal cancer                   30   Soft-tissue sarcoma
  11   Esophageal cancer                   31   Spinal tumor
  12   Gallbladder cancer                  32   Stomach cancer
  13   Gestational trophoblastic disease   33   Testicular cancer
  14   Head and neck cancer                34   Thyroid cancer
  15   Hodgkin's lymphoma                  35   Uterine cancer
  16   Kidney cancer                       36   Vaginal cancer
  17   Leukemia                            37   Vulvar cancer
  18   Liver cancer                             
  19   Lung cancer                              
  20   Melanoma                                 

10.1371/journal.pone.0222508.t002

###### List of articles devoted to cancer drugs in May 2017 English Wikipedia.

This list of *N*~*d*~ = 203 cancer drugs taken from \[[@pone.0222508.ref025]\] is ordered by alphabetical order.

![](pone.0222508.t002){#pone.0222508.t002g}

       Cancer drug                     Cancer drug                   Cancer drug                       Cancer drug
  ---- ------------------------- ----- ----------------------- ----- --------------------------- ----- --------------------------
  1    Abemaciclib               52    Dactinomycin            103   Ixazomib                    154   Prednisone
  2    Abiraterone acetate       53    Daratumumab             104   Lanreotide                  155   Procarbazine
  3    Acalabrutinib             54    Dasatinib               105   Lapatinib                   156   Propranolol
  4    Afatinib                  55    Daunorubicin            106   Lenalidomide                157   Protein-bound paclitaxel
  5    Aflibercept               56    Decitabine              107   Lenvatinib                  158   Radium-223
  6    Alectinib                 57    Defibrotide             108   Letrozole                   159   Raloxifene
  7    Alemtuzumab               58    Degarelix               109   Leuprorelin                 160   Ramucirumab
  8    Amifostine                59    Denileukin diftitox     110   Lomustine                   161   Rasburicase
  9    Aminolevulinic acid       60    Denosumab               111   Megestrol acetate           162   Regorafenib
  10   Anastrozole               61    Dexamethasone           112   Melphalan                   163   Ribociclib
  11   Apalutamide               62    Dexrazoxane             113   Mercaptopurine              164   Rituximab
  12   Aprepitant                63    Dinutuximab             114   Mesna                       165   Rolapitant
  13   Arsenic trioxide          64    Docetaxel               115   Methotrexate                166   Romidepsin
  14   Asparaginase              65    Doxorubicin             116   Methylnaltrexone            167   Romiplostim
  15   Atezolizumab              66    Durvalumab              117   Midostaurin                 168   Rucaparib
  16   Avelumab                  67    Elotuzumab              118   Mitomycin C                 169   Ruxolitinib
  17   Axicabtagene ciloleucel   68    Eltrombopag             119   Mitoxantrone                170   Siltuximab
  18   Axitinib                  69    Enzalutamide            120   Necitumumab                 171   Sipuleucel-T
  19   Azacitidine               70    Epirubicin              121   Nelarabine                  172   Sonidegib
  20   Belinostat                71    Eribulin                122   Neratinib                   173   Sorafenib
  21   Bendamustine              72    Erlotinib               123   Netupitant/palonosetron     174   Sunitinib
  22   Bevacizumab               73    Etoposide               124   Nilotinib                   175   Talc
  23   Bexarotene                74    Everolimus              125   Nilutamide                  176   Talimogene laherparepvec
  24   Bicalutamide              75    Exemestane              126   Niraparib                   177   Tamoxifen
  25   Bleomycin                 76    Filgrastim              127   Nivolumab                   178   Temozolomide
  26   Blinatumomab              77    Fludarabine             128   Obinutuzumab                179   Temsirolimus
  27   Bortezomib                78    Fluorouracil            129   Ofatumumab                  180   Thalidomide
  28   Bosutinib                 79    Flutamide               130   Olaparib                    181   ThioTEPA
  29   Brentuximab vedotin       80    Folinic acid            131   Olaratumab                  182   Tioguanine
  30   Brigatinib                81    Fulvestrant             132   Omacetaxine mepesuccinate   183   Tipiracil
  31   Busulfan                  82    Gefitinib               133   Ondansetron                 184   Tisagenlecleucel
  32   Cabazitaxel               83    Gemcitabine             134   Osimertinib                 185   Tocilizumab
  33   Cabozantinib              84    Gemtuzumab ozogamicin   135   Oxaliplatin                 186   Topotecan
  34   Capecitabine              85    Glucarpidase            136   Paclitaxel                  187   Toremifene
  35   Carboplatin               86    Goserelin               137   Palbociclib                 188   Trabectedin
  36   Carfilzomib               87    HPV vaccines            138   Palifermin                  189   Trametinib
  37   Carmustine                88    Hyaluronidase           139   Palonosetron                190   Trastuzumab
  38   Ceritinib                 89    Hydroxycarbamide        140   Pamidronic acid             191   Trastuzumab emtansine
  39   Cetuximab                 90    Ibritumomab tiuxetan    141   Panitumumab                 192   Trifluridine
  40   Chlorambucil              91    Ibrutinib               142   Panobinostat                193   Uridine triacetate
  41   Chlormethine              92    Idarubicin              143   Pazopanib                   194   Valrubicin
  42   Cisplatin                 93    Idelalisib              144   Pegaspargase                195   Vandetanib
  43   Cladribine                94    Ifosfamide              145   Pegfilgrastim               196   Vemurafenib
  44   Clofarabine               95    Imatinib                146   Peginterferon               197   Venetoclax
  45   Cobimetinib               96    Imiquimod               147   Pembrolizumab               198   Vinblastine
  46   Copanlisib                97    Inotuzumab ozogamicin   148   Pemetrexed                  199   Vincristine
  47   Crizotinib                98    Interferon alfa-2b      149   Pertuzumab                  200   Vinorelbine
  48   Cyclophosphamide          99    Interleukin 2           150   Plerixafor                  201   Vismodegib
  49   Cytarabine                100   Ipilimumab              151   Pomalidomide                202   Vorinostat
  50   Dabrafenib                101   Irinotecan              152   Ponatinib                   203   Zoledronic acid
  51   Dacarbazine               102   Ixabepilone             153   Pralatrexate                      

The paper is composed as follows: the section "Description of data sets and methods" will present the May 2017 English Wikipedia network, introduce the Google matrix, the PageRank and CheiRank algorithms, and explain the construction of reduced Google matrices. In this section the node influence is defined through the PageRank ranking and the PageRank sensitivity. In the section "Results" we present the influence of cancer devoted pages in Wikipedia and extract a cancer ranking which is compared to cancer rankings extracted from GBD study \[[@pone.0222508.ref005]\] and GLOBOCAN \[[@pone.0222508.ref002]\] databases. We also use the reduced Google matrix to construct a reduced network of cancers and we determine the interaction of cancers with countries and cancer drugs. We corroborate the results obtained from the network structure of Wikipedia articles with various disease burden and/or epidemiological studies. To our knowledge, it is the first time that such correspondence is established. Finally we compare cancer prescriptions obtained from May 2017 English Wikipedia network analysis with approved medications reported in National Cancer Institute \[[@pone.0222508.ref025]\] and DrugBank \[[@pone.0222508.ref029]\]. The last section presents the conclusion of this research.

Description of data sets and methods {#sec002}
====================================

Network of English Wikipedia articles of 2017 {#sec003}
---------------------------------------------

We analyze the English language edition of Wikipedia collected in May 2017 (ENWIKI2017) \[[@pone.0222508.ref030]\] containing *N* = 5 416 537 articles (nodes) connected by *N*~*l*~ = 122 232 932 directed hyperlinks between articles (without self-citations). From this data set we extract the *N*~*cr*~ = 37 types of cancers listed at \[[@pone.0222508.ref024]\]. From \[[@pone.0222508.ref025]\] we also collect names of drugs related to cancer diseases obtaining the list of *N*~*d*~ = 203 drugs present at Wikipedia. The lists of 37 cancer types and 203 drugs are given in [Table 1](#pone.0222508.t001){ref-type="table"} and [2](#pone.0222508.t002){ref-type="table"}. This reduced set of *N*~*r*~ = 240 nodes is illustrated in the inset of [Fig 1](#pone.0222508.g001){ref-type="fig"}. For global influence investigations, it is complemented by *N*~*cn*~ = 195 world countries listed in \[[@pone.0222508.ref028]\]. Thus in total we have the reduced network of *N*~*r*~ = *N*~*cr*~ + *N*~*d*~ + *N*~*cn*~ = 435 ≪ *N* nodes embedded in the global network with more than 5 millions nodes. All data sets are available at \[[@pone.0222508.ref028]\]. The present study complies with Wikimedia terms of use.

![Subnetworks of cancers and cancer drugs in May 2017 English Wikipedia.\
Bottom right inset: subnetwork of *N*~*r*~ = 240 articles comprising *N*~*cr*~ = 37 articles devoted to cancers (green nodes) and *N*~*d*~ = 203 articles devoted to cancer drugs (golden nodes). Main figure: subnetwork of top 20 cancers and top 20 cancer drugs extracted from the ranking of 2017 English Wikipedia using PageRank algorithm (see [Table 3](#pone.0222508.t003){ref-type="table"}). The bulk of the other Wikipedia articles is not shown. Arrows symbolize hyperlinks between cancer and cancer drug articles in the global Wikipedia.](pone.0222508.g001){#pone.0222508.g001}

Google matrix construction rules {#sec004}
--------------------------------

The construction rules of Google matrix *G* are described in detail in \[[@pone.0222508.ref006]--[@pone.0222508.ref008]\]. Thus the Google matrix *G* is built from the adjacency matrix *A*~*ij*~ with elements 1 if article (node) *j* points to article (node) *i* and zero otherwise. The Google matrix elements have the standard form *G*~*ij*~ = *αS*~*ij*~ + (1 − *α*)/*N* \[[@pone.0222508.ref006]--[@pone.0222508.ref008]\], where *S* is the matrix of Markov transitions with elements *S*~*ij*~ = *A*~*ij*~/*k*~*out*~(*j*). Here $k_{out}\left( j \right) = \sum_{i = 1}^{N}A_{ij} \neq 0$ is the out-degree of node *j* (number of outgoing links) and *S*~*ij*~ = 1/*N* if *j* has no outgoing links (dangling node). The parameter 0 \< *α* \< 1 is the damping factor. For a random surfer, jumping from one node to another, it gives the probability (1 − *α*) to jump to any node. Below we use the standard value *α* = 0.85 \[[@pone.0222508.ref007]\] noting that for the range 0.5 ≤ *α* ≤ 0.95 the results are not sensitive to *α* \[[@pone.0222508.ref007], [@pone.0222508.ref008]\].

The right PageRank eigenvector of *G* is the solution of the equation *GP* = λ*P* with the unit eigenvalue λ = 1. The PageRank components *P*(*j*) give positive probabilities to find a random surfer on a node *j* after an infinite journey (∑~*j*~ *P*(*j*) = 1). The numerical computation of *P*(*j*) is done efficiently with the PageRank algorithm described in \[[@pone.0222508.ref006], [@pone.0222508.ref007]\].

The node influence is measured from the PageRank algorithm. We sort network nodes by decreasing PageRank probabilities. We assign *K* = 1 index to the node with maximal probability, i.e., the most central node according to PageRank algorithm, *K* = 2 index to the node with the second biggest probability, ...A recursive definition of the PageRank algorithm can be given: a node is all the more influential as it is pointed by influential nodes.

It is also useful to consider the network with inverted direction of links. After links inversion $A_{ij}^{*} = A_{ji}$, the Google matrix *G*\* is constructed within the same procedure with *G*\**P*\* = *P*\*. The matrix *G*\* has its own PageRank vector *P*\* called CheiRank \[[@pone.0222508.ref031]\] (see also \[[@pone.0222508.ref008], [@pone.0222508.ref032]\]). Its probability values can be again ordered in a decreasing order with CheiRank index *K*\* with highest *P*\*(*j*) at *K*\* = 1 and smallest at *K*\* = *N*. The CheiRank algorithm measures the node diffusivity. A recursive definition of the CheiRank algorithm can also be given: a node is all the more diffusive as it is pointed by diffusive nodes.

On average, the high values of *P*(*j*) (*P*\*(*j*)) correspond to nodes *j* with many ingoing (outgoing) links \[[@pone.0222508.ref008]\].

The PageRank order list of 37 cancers and 203 drugs is given in [Table 3](#pone.0222508.t003){ref-type="table"}. In the global ENWIKI2017 network, countries are located on top PageRank positions (1. *USA*, 4. *France*, 5. *Germany*) so that cancers and drugs are located well below them since the first cancer type, i.e. *Lung cancer*, appears at 3 478th position, and the first cancer drug, i.e. *Talc*, appears at 22 177th position (see [Fig 2](#pone.0222508.g002){ref-type="fig"}). As expected cancer types have a more central position than cancer drugs. The network of 40 nodes and their direct links is shown in [Fig 1](#pone.0222508.g001){ref-type="fig"} for the top 20 PageRank nodes of cancers and drugs (ordered separately for cancers and drugs). We see that already only for 40 nodes the network structure is rather complex. Here and below the networks are drawn with Cytoscape \[[@pone.0222508.ref033]\].

10.1371/journal.pone.0222508.t003

###### Ranking of articles devoted to cancer types and to cancer drugs in May 2017 English Wikipedia using PageRank algorithm.

Cancer types are highlighted in boldface.

![](pone.0222508.t003){#pone.0222508.t003g}

  *K*~*r*~   *K*~*cr*~   *K*~*d*~   Cancer/drug                                            *K*~*r*~   *K*~*cr*~   *K*~*d*~   Cancer/drug                                          *K*~*r*~   *K*~*cr*~   *K*~*d*~   Cancer/drug       *K*~*r*~   *K*~*cr*~   *K*~*d*~   Cancer/drug                                       *K*~*r*~   *K*~*d*~   Drug
  ---------- ----------- ---------- ------------------------------------------------------ ---------- ----------- ---------- ---------------------------------------------------- ---------- ----------- ---------- ----------------- ---------- ----------- ---------- ------------------------------------------------- ---------- ---------- ------------------
  1          **1**                  **Lung**                                               49                     22         Trastuzumab                                          97                     65         Mitoxantrone      145                    110        Eribulin                                          193        156        Ixazomib
  2          **2**                  **Breast**                                             50                     23         Vinblastine                                          98         **33**                 **Gallbladder**   146                    111        Panitumumab                                       194        157        Lenvatinib
  3          **3**                  **Leukemia**                                           51         **28**                 **NETs** [^c^](#t003fn004){ref-type="table-fn"}      99                     66         Vemurafenib       147                    112        Ofatumumab                                        195        158        Trifluridine
  4          **4**                  **Prostate**                                           52                     24         Bleomycin                                            100                    67         Topotecan         148        **36**                 **Adrenal**                                       196        159        Ponatinib
  5          **5**                  **Colorectal**                                         53                     25         Carboplatin                                          101                    68         Fludarabine       149                    113        Sipuleucel-T                                      197        160        Alectinib
  6          **6**                  **Brain**                                              54                     26         Mercaptopurine                                       102                    69         Pembrolizumab     150                    114        Pamidronic                                        198        161        Nilutamide
  7          **7**                  **Pancreatic**                                         55                     27         Docetaxel                                            103                    70         Tioguanine        151                    115        Cabozantinib                                      199        162        Daratumumab
  8          **8**                  **Melanoma**                                           56                     28         Daunorubicin                                         104                    71         Dacarbazine       152                    116        Brentuximab                                       200        163        Valrubicin
  9          **9**                  **Stomach**                                            57                     29         Hyaluronidase                                        105                    72         Azacitidine       153                    117        Gemtuzumab                                        201        164        Sonidegib
  10         **10**                 **Ovarian**                                            58                     30         Etoposide                                            106        **34**                 **Vaginal**       154                    118        Enzalutamide                                      202        165        Osimertinib
  11         **11**                 **Cervical**                                           59                     31         Bortezomib                                           107                    73         Carmustine        155                    119        Pegfilgrastim                                     203        166        Pertuzumab
  12         **12**                 **Hodgkin's**                                          60                     32         Irinotecan                                           108                    74         Decitabine        156                    120        Romidepsin                                        204        167        Defibrotide
  13         **13**                 **Skin**                                               61         **29**                 **Soft-tissue**                                      109                    75         Bicalutamide      157                    121        Rasburicase                                       205        168        Bexarotene
  14                     1          Talc                                                   62                     33         Oxaliplatin                                          110                    76         Flutamide         158                    122        Bendamustine                                      206        169        Palifermin
  15         **14**                 **M. myeloma**                                         63                     34         Melphalan                                            111        **35**                 **Vulvar**        159                    123        Interferon                                        207        170        Idelalisib
  16         **15**                 **Esophageal**                                         64                     35         Leuprorelin                                          112                    77         Procarbazine      160                    124        Obinutuzumab                                      208        171        Toremifene
  17         **16**                 **Liver**                                              65                     36         Raloxifene                                           113                    78         Cladribine        161                    125        Denileukin                                        209        172        Apalutamide
  18         **17**                 **Non-Hodgkin**                                        66                     37         Hydroxycarb.[^d^](#t003fn005){ref-type="table-fn"}   114                    79         Tocilizumab       162                    126        Ruxolitinib                                       210        173        Regorafenib
  19         **18**                 **Bladder**                                            67                     38         Aminolevulinic                                       115                    80         Busulfan          163                    127        Talimogene                                        211        174        Venetoclax
  20                     2          Methotrexate                                           68                     39         Cytarabine                                           116                    81         Denosumab         164                    128        Belinostat                                        212        175        Dexrazoxane
  21         **19**                 **Head & Neck**                                        69                     40         Cetuximab                                            117                    82         Pemetrexed        165                    129        Eltrombopag                                       213        176        Avelumab
  22                     3          Thalidomide                                            70                     41         Folinic acid                                         118                    83         Lomustine         166                    130        Cabazitaxel                                       214        177        Dinutuximab
  23         **20**                 **Testicular**                                         71                     42         Mitomycin C                                          119                    84         Vinorelbine       167                    131        Lanreotide                                        215        178        Ramucirumab
  24                     4          Paclitaxel                                             72         **30**                 **Anal**                                             120                    85         Nivolumab         168                    132        Palbociclib                                       216        179        Blinatumomab
  25                     5          Prednisone                                             73                     43         Gemcitabine                                          121                    86         Dabrafenib        169                    133        Pomalidomide                                      217        180        Rolapitant
  26                     6          Cisplatin                                              74                     44         Sorafenib                                            122                    87         Letrozole         170                    134        Trastuzumab                                       218        181        Niraparib
  27                     7          Dexamethasone                                          75                     45         Imiquimod                                            123                    88         Fulvestrant       171                    135        Vismodegib                                        219        182        Pralatrexate
  28         **21**                 **Thyroid**                                            76         **31**                 **Spinal**                                           124                    89         Radium-223        172        **37**                 **Appendix**                                      220        183        Acalabrutinib
  29                     8          Doxorubicin                                            77                     46         Sunitinib                                            125                    90         Olaparib          173                    136        Omacetaxine                                       221        184        Brigatinib
  30         **22**                 **Bone**                                               78                     47         Ifosfamide                                           126                    91         Pazopanib         174                    137        Plerixafor                                        222        185        Necitumumab
  31                     9          Propranolol                                            79                     48         Erlotinib                                            127                    92         Dasatinib         175                    138        Lapatinib                                         223        186        Midostaurin
  32                     10         Interleukin 2                                          80                     49         Asparaginase                                         128                    93         Idarubicin        176                    139        Clofarabine                                       224        187        Rucaparib
  33         **23**                 **Kidney**                                             81                     50         Gefitinib                                            129                    94         Temsirolimus      177                    140        Vandetanib                                        225        188        Inotuzumab
  34         **24**                 **Mesothelioma**                                       82         **32**                 **GTD** [^e^](#t003fn006){ref-type="table-fn"}       130                    95         Exemestane        178                    141        Axitinib                                          226        189        Pegaspargase
  35                     11         Cyclophospha.[^a^](#t003fn002){ref-type="table-fn"}    83                     51         Anastrozole                                          131                    96         Crizotinib        179                    142        Ibrutinib                                         227        190        Durvalumab
  36                     12         Fluorouracil                                           84                     52         Epirubicin                                           132                    97         Zoledronic        180                    143        Methylnal[^g^](#t003fn008){ref-type="table-fn"}   228        191        Siltuximab
  37         **25**                 **Oral**                                               85                     53         Lenalidomide                                         133                    98         Panobinostat      181                    144        Carfilzomib                                       229        192        Ribociclib
  38                     13         Tamoxifen                                              86                     54         Capecitabine                                         134                    99         Mesna             182                    145        Protein-bound                                     230        193        Degarelix
  39                     14         Vincristine                                            87                     55         Vorinostat                                           135                    100        Ibritumomab       183                    146        Bosutinib                                         231        194        Neratinib
  40                     15         Rituximab                                              88                     56         Chlormethine                                         136                    101        Trametinib        184                    147        Ceritinib                                         232        195        Abemaciclib
  41                     16         Bevacizumab                                            89                     57         Everolimus                                           137                    102        Nilotinib         185                    148        Abiraterone                                       233        196        Olaratumab
  42                     17         HPV vaccines                                           90                     58         Alemtuzumab                                          138                    103        Ixabepilone       186                    149        Trabectedin                                       234        197        Copanlisib
  43                     18         Imatinib                                               91                     59         Chlorambuci.[^f^](#t003fn007){ref-type="table-fn"}   139                    104        Megestrol         187                    150        Elotuzumab                                        235        198        Netupitant
  44                     19         Arsenic trioxide                                       92                     60         Filgrastim                                           140                    105        Romiplostim       188                    151        Nelarabine                                        236        199        Tipiracil
  45         **26**                 **Uterine**                                            93                     61         Goserelin                                            141                    106        Afatinib          189                    152        Palonosetron                                      237        200        Uridine
  46                     20         Dactinomycin                                           94                     62         Ipilimumab                                           142                    107        ThioTEPA          190                    153        Cobimetinib                                       238        201        Axicabtagene
  47         **27**                 **Cholangio**.[^b^](#t003fn003){ref-type="table-fn"}   95                     63         Temozolomide                                         143                    108        Aprepitant        191                    154        Amifostine                                        239        202        Glucarpidase
  48                     21         Ondansetron                                            96                     64         Peginterferon                                        144                    109        Aflibercept       192                    155        Atezolizumab                                      240        203        Tisagenlecleucel

Notes: here words "cancer", "tumor", "lymphoma", "sarcoma" have been removed from cancer type denominations;

^a^Cyclophosphamide;

^b^Cholangiocarcinoma;

^c^Neuroendocrine tumors;

^d^Hydroxycarbamide;

^e^Gestational trophoblastic disease;

^f^Chlorambucil;

^g^Methylnaltrexone.

![Density of May 2017 English Wikipedia articles in the CheiRank *K*\*---PageRank *K* plane.\
Data are averaged over a 100 × 100 grid spanning the (log~10~ *K*, log~10~ *K*\*) ∈\[0, log~10~ *N*\] × \[0, log~10~ *N*\] domain. Density of articles ranges from very low density (purple tiles) to very high density (bright yellow tiles). The absence of article is represented by black tiles. The superimposed green (gold) circles give the positions of May 2017 English Wikipedia articles devoted to cancers (cancer drugs) listed in [Table 1](#pone.0222508.t001){ref-type="table"} ([Table 2](#pone.0222508.t002){ref-type="table"}). For comparison, the gray (blue) open circles give the positions of pages devoted to sovereign countries (infectious diseases) in May 2017 English Wikipedia.](pone.0222508.g002){#pone.0222508.g002}

Reduced Google matrix algorithm {#sec005}
-------------------------------

The details of REGOMAX method are described in \[[@pone.0222508.ref016], [@pone.0222508.ref017], [@pone.0222508.ref020]\]. It captures in the reduced Google matrix of size *N*~*r*~ × *N*~*r*~ the full contribution of direct and indirect pathways existing in the full Google matrix between *N*~*r*~ nodes of interest. The reduced Google matrix *G*~R~ is such as *G*~R~*P*~*r*~ = *P*~*r*~ where *P*~*r*~ is its associated PageRank probability vector. The PageRank probabilities *P*~*r*~(*j*) of the selected *N*~*r*~ nodes are the same as for the global network with *N* nodes, up to a constant multiplicative factor taking into account that the sum of PageRank probabilities over *N*~*r*~ nodes is unity. The computation of *G*~R~ provides a decomposition into matrices that clearly distinguish direct from indirect interactions: *G*~R~ = *G*~*rr*~ + *G*~pr~ + *G*~qr~ \[[@pone.0222508.ref017]\]. Here *G*~*rr*~ is the *N*~*r*~ × *N*~*r*~ submatrix of the *N* × *N* global Google matrix *G* encoding the direct links between the selected *N*~*r*~ nodes. The G~pr~ matrix is rather close to the matrix in which each column is given by the PageRank vector *P*~*r*~, ensuring that PageRank probabilities of *G*~R~ are the same as for *G* (up to a constant multiplier). Thus G~pr~ does not provide much more information about direct and indirect links between selected nodes than the usual Google matrix analysis described in the previous section. The component playing an interesting role is *G*~qr~, which takes into account all indirect links between selected nodes appearing due to multiple paths via the global network of *N* nodes (see \[[@pone.0222508.ref016], [@pone.0222508.ref017]\]). The matrix *G*~qr~ = *G*~qrd~ + *G*~qrnd~ has diagonal (*G*~qrnd~) and non-diagonal (*G*~qrnd~) parts. Thus *G*~qrnd~ describes indirect interactions between nodes. The explicit formulas as well as the mathematical and numerical computation methods of all three components of *G*~R~ are given in \[[@pone.0222508.ref016], [@pone.0222508.ref017], [@pone.0222508.ref020]\].

With the reduced Google matrix *G*~R~ and its components we can analyze the PageRank sensitivity in respect to specific links between *N*~*r*~ nodes. To measure the sensitivity of a country *cn* to a cancer *cr* we change the matrix element (*G*~*R*~)~*cn*,*cr*~ by a factor (1+*δ*) with *δ* ≪ 1 and renormalize to unity the sum of the column elements associated with cancer *cr*, and we compute the logarithmic derivative of PageRank probability *P*(*cn*) associated to country *cn*: *D*(*cr* → *cn*, *cn*) = *d* ln *P*(*cn*)/*dδ* (diagonal sensitivity). It is also possible to consider the nondiagonal (or indirect) sensitivity *D*(*cr* → *cn*, *cn*′) = *d* ln *P*(*cn*′)/*dδ* when the variation is done for the link from *cr* to *cn* and the derivative of PageRank probability is computed for another country *cn*′. Also instead of the link *cr* → *cn* we can consider the link from a cancer *cr* to a drug *d* computing then the nondiagonal sensitivity of country *cn*′. The PageRank sensitivity approach, already used in \[[@pone.0222508.ref026], [@pone.0222508.ref027]\], allows to measure the sensitivity of a node influence with respect to the change of a link intensity. Pragmatically it measures the increase or decrease of influence of a node *A* caused by an increase of the intensity of the link from a node *B* to a node *C*.

Results {#sec006}
=======

Cancer distribution on PageRank-CheiRank plane {#sec007}
----------------------------------------------

The PageRank order of 37 cancers and 203 cancer drugs is given in [Table 3](#pone.0222508.t003){ref-type="table"}. In the top 3 positions we find *Lung, Breast, Leukemia* cancers. *Lung* and *Breast cancers* have indeed the two highest incidences \[[@pone.0222508.ref002]\] and *Leukemia* is the most frequent type of cancer in children and young adults \[[@pone.0222508.ref034]\]. In general in the PageRank order of 240 cancers and drugs, cancers occupy predominantly the top positions. The first three drugs are *Talc, Methotrexate, Thalidomide*, taking positions 14, 20, 22. The top position of *Talc* among cancer drugs may be explained by its industrial use and also by both potential carcinogenic and anticancer effects \[[@pone.0222508.ref035]\]. *Methotrexate* can be used in the most frequent types of cancer but also in autoimmune diseases and for medical abortions \[[@pone.0222508.ref036]\]. The third position of *Thalidomide* among cancer drugs may be explained by its high potential for the treatment of cancers but also for its well-known teratogenic effect; this teratogenic effect may by itself contribute to its prominence in Wikipedia. It is also used for treatment of other diseases than cancers (tuberculosis, graft-versus-host disease,...) \[[@pone.0222508.ref037]\]. The list of these 240 articles in CheiRank order is also given in \[[@pone.0222508.ref028]\].

The distribution of selected articles on the global PageRank-CheiRank plane of the whole Wikipedia network with *N* = 5 416 537 nodes are shown in [Fig 2](#pone.0222508.g002){ref-type="fig"}. The top PageRank positions are taking by the world countries as discussed in \[[@pone.0222508.ref008], [@pone.0222508.ref026]\] marked by gray open circles. Then there is a group of cancers (above *K* ∼ 3 × 10^3^ and *K*\* ∼ 10^4^), marked by green points, followed by drugs (mostly above *K* ∼ 10^4^ and *K*\* ∼ 10^5^), marked by gold points. There is a certain overlap between cancers and drugs on this plane but in global there is a clear separation between these two groups. As a comparison we also mark the positions of 230 infectious diseases by open blue circles. These 230 articles are studied in \[[@pone.0222508.ref027]\] in the frame of Wikipedia network analysis. The global PageRank list of 230 infectious diseases and 37 cancers is given in \[[@pone.0222508.ref028]\]. In this list *Lung cancer* is located at the 7th position. From [Fig 2](#pone.0222508.g002){ref-type="fig"} we observe these two types of diseases occupy somewhat the same (*K*, *K*\*) region (mostly above *K*\* ∼ 10^5^ and above *K* ∼ 3 × 10^3^) suggesting that cancer types and infectious diseases have globally the same influence in May 2017 English Wikipedia with the exception of the first six infectious diseases, *Tuberculosis* (*K* = 639), *HIV/AIDS* (*K* = 810), *Malaria* (*K* = 1116), *Pneumonia* (*K* = 1531), *Smallpox* (*K* = 1532), *Cholera* (*K* = 2300) which are causing or have caused pandemics or notable epidemics. The first three cancer types, i.e. *Lung cancer*, *Breast cancer*, and *Leukemia*, appear at positions *K* = 3478, 3788, and 3871 just before *Influenza* at *K* = 4191.

The 240 cancer types and drugs placed on the plane of local PageRank indices *K*~*r*~ ∈ {1, ..., 240} and CheiRank indices $K_{r}^{*} \in \left\{ 1,\ldots,240 \right\}$ is shown in [Fig 3](#pone.0222508.g003){ref-type="fig"}. We retrieve the fact that cancer types occupy the top positions in *K*~*r*~ and in $K_{r}^{*}$. Indeed the first 14 most influent articles of this subset (*K* ≤ 14), which appear to be devoted to cancer types, are also the most communicative with the exception of articles devoted to drugs *Paclitaxel* $\left( K_{r} = 24,K_{r}^{*} = 6 \right)$ and *Bicalutamide* $\left( K_{r} = 109,K_{r}^{*} = 2 \right)$. *Paclitaxel* \[[@pone.0222508.ref038]\] is a chemotherapy medication used to treat a wide range of cancer types e.g. *Ovarian cancer, Breast cancer, Lung cancer, Pancreatic cancer*, etc. Moreover *Paclitaxel* article cites *Ovarian cancer* article $\left( K_{r} = 10,K_{r}^{*} = 1 \right)$ which is a very communicative article since the *Ovarian cancer* article CheiRank index, *K*\* = 29 317, is about one order magnitude lower than the CheiRank indexes, *K*\* ≳ 10^5^, of the other 239 considered articles (see [Fig 2](#pone.0222508.g002){ref-type="fig"}). The wide applications of *Paclitaxel* and the citation of *Ovarian cancer* article explain the very good ranking of this cancer drug in the CheiRank scale. On the other hand, the $K_{r}^{*} = 2$ rank of the *Bicalutamide* article (see [Fig 3](#pone.0222508.g003){ref-type="fig"}), devoted to an antiandrogen medication mainly used to treat *Prostate cancer*, is due to a very long article with a high density of intra-wiki citations \[[@pone.0222508.ref039]\]. Like the *Paclitaxel* article, the *Bicalutamide* article cites also the *Ovarian cancer* since this medication has already been tried for this cancer type \[[@pone.0222508.ref039]\].

![Distribution of the May 2017 English Wikipedia articles devoted to cancers and drug cancers in the local CheiRank $K_{r}^{*}$---PageRank *K*~*r*~ plane.\
The *N*~*cr*~ = 37 (*N*~*d*~ = 203) articles devoted to cancers (drug cancers) are represented by green (gold) plain circles.](pone.0222508.g003){#pone.0222508.g003}

The three most influent cancer drugs in ENWIKI2017 are *Talc*, *K*~*r*~ = 14, which is used to prevent blood effusions, e.g., in *Lung cancer* or *Ovarian cancer* \[[@pone.0222508.ref035]\], *Methotrexate*, *K*~*r*~ = 20, which is a chemotherapy agent used for the treatment *Breast cancer, Leukemia, Lung cancer, Lymphoma*, etc \[[@pone.0222508.ref036]\], and *Thalidomide*, *K*~*r*~ = 22, which is a drug modulating the immune system used, e.g., for *Multiple myeloma* treatment \[[@pone.0222508.ref037]\]. Although *Talc* is widely used in chemical, pharmaceutical and food industries \[[@pone.0222508.ref035]\], its global PageRank position is nevertheless of the same order than the PageRank position of the second most influent cancer drug in Wikipedia, i.e., *Methotrexate*, which is a drug more specific to cancers \[[@pone.0222508.ref036]\].

Comparison of Wikipedia network analysis with GBD study 2017 and GLOBOCAN 2018 for cancer significance {#sec008}
------------------------------------------------------------------------------------------------------

We perform the comparison of cancer significance given by the GBD study 2017 \[[@pone.0222508.ref005]\], the GLOBOCAN 2018 \[[@pone.0222508.ref002]\], and the Wikipedia network analysis. We extract the rankings of cancer types by the number of deaths in 2017 estimated by the 2017 GBD study \[[@pone.0222508.ref040]\] (see [Table 4](#pone.0222508.t004){ref-type="table"}) and by the number of disability-adjusted life years (DALYs) estimated by the 2017 GBD study \[[@pone.0222508.ref041]\] (see [Table 4](#pone.0222508.t004){ref-type="table"}). Also, we extract the rankings of cancer types by the number of deaths and by the number of new cases in 2018 estimated by the GLOBOCAN 2018 \[[@pone.0222508.ref004]\] (see [Table 5](#pone.0222508.t005){ref-type="table"}). In [Fig 4](#pone.0222508.g004){ref-type="fig"}, we show the overlap of these 4 rankings with the extracted ranking of cancer types obtained from the ENWIKI2017 PageRanking (see bold items in [Table 3](#pone.0222508.t003){ref-type="table"}). We observe that the ranking obtained from the Wikipedia network analysis provides a reliable cancer types ranking since its top 10 (top 20) shares about 70% (80%) similarity with GBD study data and GLOBOCAN data. The Wikipedia top 5 reaches even 80% similarity with top 5 cancer types extracted from the estimated number of new cases in 2018.

10.1371/journal.pone.0222508.t004

###### List of cancer types ordered by the estimated number of deaths during the year 2017 (A) and by the estimated disability-adjusted life years (DALYs) for 2017 (B).

Data extracted from GBD Study \[[@pone.0222508.ref040], [@pone.0222508.ref041]\].

![](pone.0222508.t004){#pone.0222508.t004g}

  A    B                                                           
  ---- ---------------------- -------- ---- ---------------------- -------
  1    Lung cancer            1883.1   1    Lung cancer            40900
  2    Colorectal cancer      896.0    2    Liver cancer           20800
  3    Stomach cancer         865.0    3    Stomach cancer         19100
  4    Liver cancer           819.4    4    Colorectal cancer      19000
  5    Breast cancer          611.6    5    Breast cancer          17700
  6    Pancreatic cancer      441.1    6    Leukemia               12000
  7    Esophageal cancer      436.0    7    Head and neck cancer   10600
  8    Prostate cancer        415.9    8    Esophageal cancer      9780
  9    Head and neck cancer   380.6    9    Pancreatic cancer      9080
  10   Leukemia               347.6    10   Brain tumor            8740
  11   Cervical cancer        259.7    11   Cervical cancer        8060
  12   Non-Hodgkin lymphoma   248.6    12   Prostate cancer        7060
  13   Brain tumor            247.1    13   Non-Hodgkin lymphoma   7020
  14   Bladder cancer         196.5    14   Ovarian cancer         4670
  15   Ovarian cancer         176.0    15   Bladder cancer         3600
  16   Gallbladder cancer     174.0    16   Gallbladder cancer     3480
  17   Kidney cancer          138.5    17   Kidney cancer          3280
  18   Skin cancer            126.8    18   Skin cancer            2980
  19   Multiple myeloma       107.1    19   Multiple myeloma       2330
  20   Uterine cancer         85.2     20   Uterine cancer         2140
  21   Thyroid cancer         41.2     21   Hodgkin's lymphoma     1380
  22   Hodgkin's lymphoma     32.6     22   Thyroid cancer         1130
  23   Mesothelioma           29.9     23   Mesothelioma           671
  24   Testicular cancer      7.7      24   Testicular cancer      375

10.1371/journal.pone.0222508.t005

###### List of cancer types ordered by the estimated number of deaths during the year 2018 (A) and by the estimated number of new cases in 2018 (B).

Data extracted from GLOBOCAN 2018 \[[@pone.0222508.ref004]\].

![](pone.0222508.t005){#pone.0222508.t005g}

  A    B                                                           
  ---- ---------------------- -------- ---- ---------------------- --------
  1    Lung cancer            1761.0   1    Lung cancer            2093.9
  2    Colorectal cancer      861.7    2    Breast cancer          2088.8
  3    Stomach cancer         782.7    3    Colorectal cancer      1801.0
  4    Liver cancer           781.6    4    Prostate cancer        1276.1
  5    Breast cancer          626.7    5    Skin cancer            1042.1
  6    Esophageal cancer      508.6    6    Stomach cancer         1033.7
  7    Head and neck cancer   453.3    7    Head and neck cancer   887.7
  8    Pancreatic cancer      432.2    8    Liver cancer           841.1
  9    Prostate cancer        359.0    9    Esophageal cancer      572.0
  10   Cervical cancer        311.4    10   Cervical cancer        569.8
  11   Leukemia               309.0    11   Thyroid cancer         567.2
  12   Non-Hodgkin lymphoma   248.7    12   Bladder cancer         549.4
  13   Brain tumor            241.0    13   Non-Hodgkin lymphoma   509.6
  14   Bladder cancer         199.9    14   Pancreatic cancer      458.9
  15   Ovarian cancer         184.8    15   Leukemia               437.0
  16   Kidney cancer          175.1    16   Kidney cancer          403.3
  17   Gallbladder cancer     165.1    17   Uterine cancer         382.1
  18   Multiple myeloma       106.1    18   Brain tumor            296.9
  19   Uterine cancer         89.9     19   Ovarian cancer         295.4
  20   Skin cancer            65.2     20   Melanoma               287.7
  21   Melanoma               60.7     21   Gallbladder cancer     219.4
  22   Thyroid cancer         41.1     22   Multiple myeloma       160.0
  23   Hodgkin lymphoma       26.2     23   Hodgkin lymphoma       80.0
  24   Mesothelioma           25.6     24   Testicular cancer      71.1

![Comparison between cancer rankings extracted from May 2017 English Wikipedia PageRank, from the global burden of disease (GBD) study 2017 data, and from GLOBOCAN 2018 data.\
The overlap *η*(*j*) gives the number of cancer types in common in the top *j* of the ranking of cancers obtained from the May 2017 English Wikipedia PageRank (see bold terms in [Table 3](#pone.0222508.t003){ref-type="table"}) and in the top *j* of the ranking of cancers by estimated number of worldwide deaths from GBD 2017 data \[[@pone.0222508.ref040]\] (black line, see [Table 4](#pone.0222508.t004){ref-type="table"}), by estimation of disability-adjusted life years from GBD 2017 data \[[@pone.0222508.ref041]\] (black dashed line, [Table 4](#pone.0222508.t004){ref-type="table"}), by estimated number of worldwide deaths from GLOBOCAN 2018 data \[[@pone.0222508.ref004]\] (red line, [Table 5](#pone.0222508.t005){ref-type="table"}), and by estimated number of new cases from GLOBOCAN 2018 data \[[@pone.0222508.ref004]\] (red dashed line, [Table 5](#pone.0222508.t005){ref-type="table"}). Only the black plain line is visible, where black plain line, red plain line and black dashed line overlap, e.g., from *j* = 1 to *j* = 5.](pone.0222508.g004){#pone.0222508.g004}

Reduced Google matrix of cancers and drugs {#sec009}
------------------------------------------

Let us consider now the subset of *N*~*r*~ = 40 nodes composed of the first 20 cancers and the first 20 cancer drugs of the ENWIKI2017 PageRanking ([Table 3](#pone.0222508.t003){ref-type="table"}). For this sub-network of interest illustrated in [Fig 1](#pone.0222508.g001){ref-type="fig"}, we perform the calculation of the reduced Google matrix *G*~R~ and its components *G*~*rr*~, G~pr~ and, G~qr~. From [Fig 5](#pone.0222508.g005){ref-type="fig"}, as expected, we observe that the *G*~R~ matrix (top left panel) is dominated by the G~pr~ component (bottom left panel) since *W*~pr~ = 0.872 *W*~R~. The G~pr~ component is of minor interest as it expresses again the relative PageRanking between the *N*~*r*~ = 40 cancers and drugs already obtained and discussed in previous sections. The *G*~*rr*~ (top right panel) gives the direct links between the considered cancers and drugs. Indeed, the *G*~*rr*~ matrix is similar to the adjacency matrix *A* since there is a one-to-one correspondence between non zero entries of *G*~*rr*~ and of *A* (for *G*~*rr*~ by non zero entry we mean an entry greater than (1 − *α*)/*N* ≃ 2.8 × 10^−8^). [Fig 1](#pone.0222508.g001){ref-type="fig"} illustrates the subnetwork of the direct links between the top 20 cancer types and the top 20 cancer drugs encoded in *G*~*rr*~ and *A*. Once the obvious G~pr~ component and the direct links *G*~*rr*~ component removed from the reduced Google matrix *G*~R~, the remaining part G~qr~ gives the hidden links between the set of *N*~*r*~ nodes of interest. In [Fig 5](#pone.0222508.g005){ref-type="fig"} we represent *G*~qrnd~ (bottom right panel), the non diagonal part of *G*~qr~. We can consider that a link with a non zero entry in *G*~qrnd~ and a zero entry in *G*~*rr*~ (consequently also in *A*) is a hidden link. Below we use the non obvious components of *G*~*rr*~ + *G*~qrnd~ to draw the structure of reduced network.

![Reduced Google matrix *G*~R~ associated to the intertwined subnetworks of top 20 cancer articles and of top 20 drug articles.\
The reduced Google matrix *G*~R~ (top left) and its 3 components *G*~*rr*~ (top right), G~pr~ (bottom left), and *G*~qrnd~ (bottom right) are shown. The weights of the components are *W*~R~ = 1, *W*~pr~ = 0.872, *W*~*rr*~ = 0.086, and *W*~qr~ = 0.042 (*W*~qrnd~ = 0.038). For each component, thin green and gold lines delimit cancers and drugs sectors, i.e. upper left sub-matrix characterizes *from cancers to cancers* interactions, lower right sub-matrix *from drugs to drugs* interactions, upper right sub-matrix *from drugs to cancers* interactions, and lower left sub-matrix *from cancers to drugs* interactions. On the *G*~qrnd~ component (bottom right) superimposed crosses indicate links already present in the adjacency matrix (otherwise stated links corresponding to non zero entries in *G*~*rr*~, see top right).](pone.0222508.g005){#pone.0222508.g005}

Reduced network of cancers {#sec010}
--------------------------

We construct the reduced Google matrix associated to the set of *N*~*r*~ = *N*~*cr*~ + *N*~*cn*~ = 232 Wikipedia articles constituted of *N*~*cr*~ = 37 articles devoted to cancer types and of *N*~*cn*~ = 195 articles devoted to countries. We consider the top 5 cancer types appearing in the ranking of May 2017 English Wikipedia using the PageRank algorithm which, according to [Table 3](#pone.0222508.t003){ref-type="table"}, are 1 *Lung cancer*, 2 *Breast cancer*, 3 *Leukemia*, 4 *Prostate cancer*, 5 *Colorectal cancer*. Let us ordinate cancer types by their relative ranking in [Table 3](#pone.0222508.t003){ref-type="table"}, cancer type *cr*~*i*~ is consequently the *i*th most influent cancer type in May 2017 English Wikipedia. Using the reduced Google matrix, the component $\left( G_{rr} + G_{\text{qrnd}} \right)_{cr_{i},cr_{j}}$, where *i*,*j* ∈ {1,...,*N*~*cr*~}, gives the non obvious strength of the link pointing from the *j*th to the *i*th most influent cancer types. From each one the top 5 cancer types, {*cr*~*j*~}~*j*∈{1,...,5}~, we select the two cancer types $cr_{i_{1}}$ and $cr_{i_{2}}$, with *i*~1~,*i*~2~ ∈ {1,...,*j* − 1,*j* + 1,...,*N*~*cr*~}, to which cancer type *cr*~*j*~ is preferentially linked ("friends"), i.e. those giving the two strongest $\left( G_{rr} + G_{\text{qrnd}} \right)_{cr_{i},cr_{j}}$ components. Around the main circle in [Fig 6](#pone.0222508.g006){ref-type="fig"} (top panel) we first place the top 5 most influent cancer types in May 2017 English Wikipedia. Then we connect each one of these cancer types to their two above defined cancer type friends. If these cancer types are not yet present in the network we add them in the vicinity of the cancer type pointing them. For each newly added cancer type we reiterate the same process until no new cancer type is added to the reduced network. The construction process of the reduced network of cancer ends at the 3rd iteration (see [Fig 6](#pone.0222508.g006){ref-type="fig"}, top panel) exhibiting only 10 of the *N*~*cr*~ = 37 cancer types, which in addition of the top 5 cancer types, are 8 *Melanoma*, 9 *Stomach cancer*, 12 *Hodgkin lymphoma*, 17 *Liver cancer* and 18 *Non-Hodgkin lymphoma*. Among these 10 cancer types, 7 are among the top 10 deadliest in 2017 according to GBD study (see [Table 4](#pone.0222508.t004){ref-type="table"}). In the reduced network of cancers showed in [Fig 6](#pone.0222508.g006){ref-type="fig"} (top panel) we observe that the most influent cancer, i.e., *Lung cancer* is pointed from all the other cancer types with the exception of *Hodgkin and Non-Hodgkin lymphomas*. Also, [Fig 6](#pone.0222508.g006){ref-type="fig"} (top panel) exhibits clearly a cluster of cancers (*Colorectal, Stomach*, and *Liver cancers*) affecting the digestive system, a cluster of cancers (*Hodgkin and Non-Hodgkin lymphomas*, and *Leukemia*) affecting blood, a loop interaction between *Prostate* and *Breast cancers* which are both linked to steroid hormone pathways and may be both treated with hormone therapy \[[@pone.0222508.ref042], [@pone.0222508.ref043]\], loop interactions between *Lung* and *Breast cancers* and between *Lung cancer* and *Melanoma* affecting mainly the thoracic region.

![Reduced network of cancers.\
We consider the reduced Google matrix associated to the *N*~*cr*~ = 37 cancers and (top panel) the *N*~*cn*~ = 195 countries, (bottom panel) the *N*~*d*~ = 203 cancer drugs. We consider the top 5 cancers from the ranking of May 2017 English Wikipedia using the PageRank algorithm: 1. *Lung cancer*, 2. *Breast cancer*, 3. *Leukemia*, 4. *Prostate cancer*, 5. *Colorectal cancer* (see [Table 3](#pone.0222508.t003){ref-type="table"}). These 5 cancers are symbolized by plain green nodes distributed around the central gray circle. We determine the two cancers to which each of these 5 cancers are preferentially linked according to (*G~rr~* + *G*~qrnd~). If not among the top 5 cancers, a newly determined cancer is placed on a gray circle centered on the cancer from which it is linked. Then for each one of the newly added cancers we determine the two best cancers to which they are each linked, and so on. This process is stopped once no new cancers can be added, i.e. at the 3rd iteration (top panel) and 4th iteration (bottom panel). Also, at each iteration the two countries (drugs) to which each cancer are preferentially linked are placed on the gray circle centered on the cancer; see top panel (bottom panel). No new links are determined from the newly added countries or drugs. On top panel, countries are represented by ring shaped nodes (red for American countries, yellow for African countries, cyan for Asian countries, blue for European countries, and orange for Oceanian countries). On bottom panel, drugs are represented by plain gold nodes. The arrows represent the directed links between cancers and from cancers to countries or drugs (1st iteration: plain line; 2nd iteration: dashed line; 3rd iteration: dotted line for top panel and dashed-dotted line for bottom panel; 4th iteration: dotted line for bottom panel). Black arrows correspond to links existing in the adjacency matrix, i.e., direct links, and red arrows are purely hidden links absent from the adjacency matrix but present in the *G*~qr~ component of the reduced Google matrix *G*~R~. These networks have been drawn with Cytoscape \[[@pone.0222508.ref033]\].](pone.0222508.g006){#pone.0222508.g006}

It is worth to note that although *Leukemia* article in May 2017 English Wikipedia does not cite any of the other articles devoted to cancer types (as an illustration the first half of the *Leukemia* column in *G*~*rr*~ is filled with zero entries, see [Fig 5](#pone.0222508.g005){ref-type="fig"} top right panel), we are able to infer hidden links (in red in [Fig 6](#pone.0222508.g006){ref-type="fig"}, top panel) from *Leukemia* to other cancers, here *Lung cancer* and *Non-Hodgkin lymphoma*.

In the reduced network of cancer, [Fig 6](#pone.0222508.g006){ref-type="fig"} (top panel), we connect to each cancer types the two preferentially linked countries, i.e., for each cancer type *cr*, the two countries *cn*~1~ and *cn*~2~ giving the two highest value $\left( G_{rr} + G_{\text{qrnd}} \right)_{cn,cr}$. We observe that cancers affecting digestive system point preferentially to Asian countries with the exception of Great Britain and Chile (*Liver cancer* points to Thailand and Saudi Arabia, *Stomach cancer* to Mongolia and Chile, *Colorectal cancer* to Philippines and Great Britain). This results are correlated to the fact that high mortality rates for *Liver cancer* are found in Asia (with the highest death rates for Eastern Asia \[[@pone.0222508.ref044]\]), and for *Stomach cancer* in Eastern Asia and South America \[[@pone.0222508.ref045], [@pone.0222508.ref046]\]. In the other hand *Colorectal cancer* epidemiology clearly states \[[@pone.0222508.ref047]\] that the highest incidence rates are found for Western countries such as Great Britain. The appearance of Philippines pointed by *Colorectal cancer* is an artifact due to the mention in the corresponding 2017 Wikipedia article of Corazon Aquino, former president of the Philippines who was diagnosed with this cancer type. Blood cancer types points preferentially to African countries with the exception of Cambodia pointed by *Hodgkin lymphoma*. At first sight this results can appear surprising since these blood cancers are found worldwide with incidence rates highest for Western countries and lowest for African countries \[[@pone.0222508.ref048]\]. In fact there is a Non-Hodgkin lymphoma, the Burkitt's lymphoma \[[@pone.0222508.ref049]\], which mainly affects children in malaria endemic region, i.e., Equatorial and Sub-Equatorial Africa and Eastern Asia. Countries pointed by blood cancer types, i.e., Liberia, Zambia, Cameroon, Gabon and Cambodia, belong to these regions. Let us note that these cancers and countries are connected through hidden links. *Melanoma* points to Australia, which is, with New Zealand \[[@pone.0222508.ref050]\], the country having the highest rate of *Melanoma*, and points to Peru, where nine 2400 years old mummies have been found with apparent signs of *Melanoma* \[[@pone.0222508.ref050]\]. *Prostate cancer* points preferentially to Japan, due to its exceptional low incidence on Japanese population in Japan and abroad \[[@pone.0222508.ref051], [@pone.0222508.ref052]\], to Nigeria, since it is believe that black population is particularly at risk \[[@pone.0222508.ref053]\]. *Lung cancer* points to Germany, where in 1929 it was shown for the first time a correlation between smoking and *Lung cancer* \[[@pone.0222508.ref054], [@pone.0222508.ref055]\], and to Bhutan which adopted a complete smoking ban since 2005 \[[@pone.0222508.ref054]\]. Hidden link from *Breast cancer* to Republic of San Marino should be related to the fact that inhabitants of San Marino commemorate Saint Agatha, patroness of the Republic and of breast cancer patients \[[@pone.0222508.ref056]\]. Hidden link from *Breast cancer* to Cambodia is more difficult to interpret.

Let us now consider the reduced Google matrix associated to *N*~*r*~ = *N*~*cr*~ + *N*~*d*~ = 240 May 2017 English Wikipedia articles devoted to *N*~*cr*~ = 37 cancer types and to *N*~*d*~ = 203 cancer drugs. As above the reduced network of cancer can be constructed ([Fig 6](#pone.0222508.g006){ref-type="fig"}, bottom panel). The construction process ends at the 4th iteration. The main structure of reduced network of cancers is the same as the previous with some exceptions. *Pancreatic cancer* is added to the digestive system cancers cluster and via hidden links, *Melanoma* points now to *Skin cancer* which points to *Breast cancer*. Consequently we observe a new cluster of thoracic region cancers comprising *Skin, Breast, Lung cancers* and *Melanoma*. Let us connect to each cancer types the two preferentially linked cancer drugs, i.e., for each cancer type *cr*, the two cancer drugs *d*~1~ and *d*~2~ giving the two highest value $\left( G_{rr} + G_{\text{qrnd}} \right)_{d,cr}$. Using DrugBank database \[[@pone.0222508.ref029]\], we easily check that indeed each drug is currently used to treat the cancer type to which it is connected. Also, closely connected cancer types share the same medication, e.g., *Skin cancer* and *Melanoma* are treated by *Vemurafenib* and *Dabrafenib* which are enzyme inhibitor of BRAF gene \[[@pone.0222508.ref057]\], *Leukemia* and *Non-Hodgkin lymphoma* are treated by the antibody *Rituximab* targeting B-lymphocyte antigen CD20 \[[@pone.0222508.ref058]\]. On the other hand non connected cancer types can in some cases share the same medication, the monoclonal antibody *Trastuzumab* typically used for *Breast cancer* is now also considered as a drug for *Stomach cancer* since these two cancer types overexpress the HER2 gene \[[@pone.0222508.ref059]\]. Let us note that hidden links connecting *Non-Hodgkin lymphoma* to *Cyclophosphamide* and *Rituximab* capture also a current medication reported in DrugBank database \[[@pone.0222508.ref029]\].

The reduced network of cancers shown in [Fig 6](#pone.0222508.g006){ref-type="fig"} depict in a relevant manner interactions between cancers, cancer-country and cancer-drug interactions through Wikipedia.

World countries sensitivity to cancers {#sec011}
--------------------------------------

We consider the reduced Google matrix associated to the set of *N*~*r*~ = *N*~*cr*~ + *N*~*cn*~ = 232 Wikipedia articles constituted of *N*~*cr*~ = 37 articles devoted to cancer types and of *N*~*cn*~ = 195 articles devoted to countries. We compute the PageRank sensitivity *D*(*cr* → *cn*,*cn*), i.e., the infinitesimal rate of variation of PageRank probability *P*(*cn*) when the directed link *cr* → *cn*, $\left( G_{R} \right)_{cn,cr}$, is increased by an amount $\delta\left( G_{R} \right)_{cn,cr}$, where *δ* is an infinitesimal.

[Fig 7](#pone.0222508.g007){ref-type="fig"} shows the world distribution of PageRank sensitivity *D*(*cr* → *cn*,*cn*) to *Lung cancer*. In [Fig 7](#pone.0222508.g007){ref-type="fig"}, color categories are obtained using the Jenks natural breaks classification method \[[@pone.0222508.ref060]\]. The most sensitive countries are, as discussed in the previous section, Bhutan and Germany mainly because these countries are directly cited in Wikipedia's *Lung cancer* article. Besides articles devoted to these two countries the others are not directly linked from the *Lung cancer* article and the results obtained in [Fig 7](#pone.0222508.g007){ref-type="fig"} (top panel) is consistent with GLOBOCAN 2018 data \[[@pone.0222508.ref004]\]: apart Micronesia/Polynesia, the most affected countries, in term of incidence rates, are Eastern Europe, Eastern Asia, Western Europe, and, Southern Europe for males, and, Northern America, Northern Europe, Western Europe, and, Australia/New Zealand for females. The less affected are African countries for both sexes. Let us note that although incidence rates are very high for males in Micronesia/Polynesia according to \[[@pone.0222508.ref004]\], this fact is not captured by Wikipedia since Nauru, Kiribati, Tuvalu, Marshall Islands are the less PageRank sensitive countries. This is certainly due to the fact that articles devoted to these sovereign states are among the worst ranked articles devoted to countries in the May 2017 English Wikipedia ranking using PageRank algorithm. Their respective ranks are Nauru *K* = 7085, Kiribati *K* = 7659, Tuvalu *K* = 6201, Marshall Islands *K* = 4549 to compare e.g. with USA *K* = 1, France *K* = 4, Germany *K* = 5, etc (see PageRank indices of countries in \[[@pone.0222508.ref028]\]).

![Sensitivity of countries to *Lung cancer*.\
A country *cn* is colored according to its diagonal PageRank sensitivity *D*(*cr* → *cn*,*cn*) to *Lung cancer*.](pone.0222508.g007){#pone.0222508.g007}

As complementary information, sensitivities of countries to *Breast cancer* and to *Leukemia* are given in \[[@pone.0222508.ref028]\].

In order to investigate cancer---drug interactions it is also possible to represent sensitivity of countries to the variation of links from a cancer to a drug. As an illustration, [Fig 8](#pone.0222508.g008){ref-type="fig"} shows countries PageRank sensitivities to variation of *Lung cancer* → *Bevacizumab* link. We see that in this case the sensitivity of countries is significantly reduced comparing to the direct sensitivity influence of lung cancer on world countries shown in [Fig 7](#pone.0222508.g007){ref-type="fig"}. Since the influence of this link variation is indirect for countries it is rather difficult to recover due to what indirect links the influence for specific countries is bigger or smaller. Among the most affected European countries we find Lichtenstein, Great Britain, Iceland, Portugal and Croatia while Germany and the Czech Republic are mostly unaffected. Another example of sensitivity of countries to cancer-drug link variation is given in \[[@pone.0222508.ref028]\].

![Sensitivity of countries to cancer → drug link variation.\
A country *cn* is colored according to its nondiagonal PageRank sensitivity *D*(*cr* → *d*,*cn*) to *cr* → *d* link variation. Variation of *Lung cancer* → *Bevacizumab* link is considered.](pone.0222508.g008){#pone.0222508.g008}

Interactions between cancers and drugs {#sec012}
--------------------------------------

Let us investigate interactions between cancers and drugs considering the subnetwork of *N*~*cr*~ = 37 cancers (see [Table 1](#pone.0222508.t001){ref-type="table"}) and of the first 37 cancer drugs appearing in the PageRank ordered list [Table 3](#pone.0222508.t003){ref-type="table"}. We do not consider *Talc* here since it is widely used in not only pharmaceutical industries.

We consider the sensitivity of cancer to drugs via the computation of *D*(*cr* → *d*,*cr*) presented in [Fig 9](#pone.0222508.g009){ref-type="fig"}. Although the PageRank sensitivity is computed using the logarithmic derivative of the PageRank, globally the most sensitives cancers are the ones with the highest PageRank probability, i.e., the ones with lowest PageRank indices *K* (see [Fig 2](#pone.0222508.g002){ref-type="fig"} and [Table 3](#pone.0222508.t003){ref-type="table"}): *Lung cancer* is mostly sensitive to *Irinotecan*, *Etoposide*, *Carboplatin*, *Breast cancer* to *Raloxifene*, *Trastuzumab*, *Docetaxel*, *Leukemia* to *Mercaptopurine*, *Imatinib*, *Rituximab*, etc. Following the National Cancer Institute \[[@pone.0222508.ref025]\] and/or DrugBank \[[@pone.0222508.ref029]\] databases, these associations cancer---drug are indeed approved.

![Sensitivity of cancers to drugs.\
The PageRank sensitivity *D*(*cr* → *d*,*cr*) of cancers to cancer drugs is represented. Here we consider the first 37 cancers (*cr*) listed in [Table 3](#pone.0222508.t003){ref-type="table"} and the first 37 drugs (*d*) listed in [Table 2](#pone.0222508.t002){ref-type="table"} (*Talc* has been removed as its article is too general).](pone.0222508.g009){#pone.0222508.g009}

[Fig 10](#pone.0222508.g010){ref-type="fig"} shows the complementary view of the sensitivity of drugs to cancers obtained from the computation of *D*(*d* → *cr*,*d*). Here the most sensitive drugs are *Dactinomycin* to *Gestational trophoblastic disease*, *HPV vaccines* to *Vulvar* and *Vaginal cancers*, *Fluorouracil* to *Anal cancer*, *Doxorubicin* to *Soft-tissue cancers*, etc. Again the National Cancer Institute \[[@pone.0222508.ref025]\] and DrugBank \[[@pone.0222508.ref029]\] databases report these possible drug---cancer associations.

![Sensitivity of drugs to cancers.\
The PageRank sensitivity *D*(*d* → *cr*,*d*) of cancer drugs to cancers is represented. Here we consider the first 37 cancers (*cr*) listed in [Table 3](#pone.0222508.t003){ref-type="table"} and the first 37 drugs (*d*) listed in [Table 2](#pone.0222508.t002){ref-type="table"} (*Talc* has been removed as its article is too general).](pone.0222508.g010){#pone.0222508.g010}

Let us consider directly the reduced Google matrix associated to the top 20 cancer types and top 20 cancer drugs according to May 2017 English Wikipedia PageRank list ([Table 3](#pone.0222508.t003){ref-type="table"}). This reduced Google matrix *G*~R~ and its *G*~*rr*~, *G*~pr~ and *G*~qrnd~ components are shown in [Fig 5](#pone.0222508.g005){ref-type="fig"}.

For each cancer *cr* of the 20 most influent cancer types in May 2017 English Wikipedia let us determine the three most connected drugs *d*, i.e., the three drugs with the highest value of $\left( G_{rr} + G_{\text{qrnd}} \right)_{d,cr}$. In [Table 6](#pone.0222508.t006){ref-type="table"} we show the May 2017 English Wikipedia prescription for each one of the top 20 cancer types. Most of the prescribed drugs are approved drugs for the considered cancer types according to National Cancer Institute \[[@pone.0222508.ref025]\] and DrugBank \[[@pone.0222508.ref029]\]. Some of the Wikipedia proposed drugs are in fact subject of passed, ongoing or planned clinical trials. Only Dexamethasone is in fact not specific to *Brain tumor* since it is a corticosteroid used to treat inflammation in many medical conditions \[[@pone.0222508.ref061]\]. We observe that hidden links gives also accurate medication, see drugs associated to *Non-Hodgkin lymphoma* and *Bladder cancer* in [Table 6](#pone.0222508.t006){ref-type="table"}.

10.1371/journal.pone.0222508.t006

###### Drug prescription by Wikipedia for the top 20 most influential cancer types and comparison with prescriptions by National Cancer Institute and DrugBank.

For each of the top 20 cancer types ranked in May 2017 English Wikipedia using PageRank algorithm (see [Table 3](#pone.0222508.t003){ref-type="table"}), we give the three strongest cancer → drug links, i.e., for a given cancer type *cr* we select the three cancer drugs *d* with the highest values $\left( G_{rr} + G_{\text{qr}} \right)_{d,cr}$. Drug with red background indicates a pure hidden cancer → drug link, i.e., the cancer type article in Wikipedia does not refer directly to the drug. For each cancer → drug link, the drug is followed by a ✔ mark if it is indeed prescribed for the cancer type according to National Cancer Institute \[[@pone.0222508.ref025]\] and/or DrugBank \[[@pone.0222508.ref029]\]; by a ▲ mark if the drug appears only as a subject of passed, ongoing or planned clinical trials reported for the cancer type in DrugBank; and by a ✘ mark otherwise.

![](pone.0222508.t006){#pone.0222508.t006g}

       Cancer                   1st drug                2nd drug                                                     3rd drug                   
  ---- ------------------------ ------------------- --- ------------------ ----------------------------------------- -------------------------- ---
  1    Lung cancer              Erlotinib           ✔   Crizotinib         ✔                                         Cisplatin                  ✔
  2    Breast cancer            Tamoxifen           ✔   Trastuzumab        ✔                                         Methotrexate               ✔
  3    Leukemia                 Imatinib            ✔   Rituximab          ✔                                         Methotrexate               ✔
  4    Prostate cancer          Enzalutamide        ✔   Cyclophosphamide   ▲                                         Prednisone                 ✔
  5    Colorectal cancer        Fluorouracil        ✔   Irinotecan         ✔                                         Bevacizumab                ✔
  6    Brain tumor              Temozolomide        ✔   Dexamethasone      ✘[^a^](#t006fn002){ref-type="table-fn"}   Aminolevulinic acid        ▲
  7    Pancreatic cancer        Fluorouracil        ✔   Gemcitabine        ✔                                         Protein-bound paclitaxel   ✔
  8    Melanoma                 Vemurafenib         ✔   Dabrafenib         ✔                                         Trametinib                 ✔
  9    Stomach cancer           Trastuzumab         ✔   Doxorubicin        ✔                                         Cisplatin                  ▲
  10   Ovarian cancer           Cisplatin           ✔   Tamoxifen          ▲                                         Bevacizumab                ✔
  11   Cervical cancer          HPV vaccines        ✔   Cisplatin          ✔                                         Topotecan                  ✔
  12   Hodgkin's lymphoma       Prednisone          ✔   Cyclophosphamide   ✔                                         Vincristine                ✔
  13   Skin cancer              Vemurafenib         ✔   Dabrafenib         ✔                                         Fluorouracil               ✔
  14   Multiple myeloma         Dexamethasone       ▲   Elotuzumab         ✔                                         Bortezomib                 ✔
  15   Esophageal cancer        Cisplatin           ✔   Carboplatin        ✔                                         Fluorouracil               ✔
  16   Liver cancer             Doxorubicin         ▲   Cisplatin          ▲                                         Sorafenib                  ✔
  17   Non-Hodgkin's lymphoma    Cyclophosphamide   ✔    Rituximab         ✔                                          Prednisone                ✔
  18   Bladder cancer            Doxorubicin        ✔    Cisplatin         ✔                                          Methotrexate              ✔
  19   Head and neck cancer     Cetuximab           ✔   Paclitaxel         ✔                                         Cisplatin                  ✔
  20   Testicular cancer        Etoposide           ✔   Cisplatin          ✔                                         Bleomycin                  ✔

Notes:

^a^ Dexamethasone may be used to decrease swelling around the tumor.

Conversely for each cancer drug *d* of the 20 most influent cancer drugs in 2007 English Wikipedia we determine the three most connected cancer types *cr*, i.e., the three cancer types with the highest value of $\left( G_{rr} + G_{\text{qrnd}} \right)_{cr,d}$. In [Table 7](#pone.0222508.t007){ref-type="table"} we show for which cancers a drug is prescribed according to May 2017 English Wikipedia. Again the results are globally in accordance with National Cancer Institute \[[@pone.0222508.ref025]\] and DrugBank \[[@pone.0222508.ref029]\] databases. We note that hidden links here correspond mainly to clinical trials, e.g., Imatinib is an approved drug for treatment of certain forms of *Leukemia*, but experiments were or will be done for *Breast cancer* and *Prostate cancer*.

10.1371/journal.pone.0222508.t007

###### According to Wikipedia for which cancer type is prescribed the top 20 most influential cancer drugs and comparison with prescriptions by National Cancer Institute and DrugBank.

For each of the top 20 cancer drugs ranked in May 2017 English Wikipedia using PageRank algorithm (see [Table 3](#pone.0222508.t003){ref-type="table"}), we give the three strongest drug → cancer links, i.e., for a given drug *d* we select the three cancer types *cr* with the highest values $\left( G_{rr} + G_{\text{qr}} \right)_{cr,d}$. Cancer type with red background indicates a pure hidden drug → cancer link, i.e., the drug article in Wikipedia does not refer directly to the cancer type. For each drug → cancer link, the cancer type is followed by a ✔ mark if the drug is indeed prescribed for the cancer type according to National Cancer Institute \[[@pone.0222508.ref025]\] and/or DrugBank \[[@pone.0222508.ref029]\]; by a ▲ mark if the drug appears only as a subject of passed, ongoing or planned clinical trials reported for the cancer type in DrugBank; and by a ✘ mark otherwise.

![](pone.0222508.t007){#pone.0222508.t007g}

       Drug               1st cancer type                                 2nd cancer type                                                  3rd cancer type       
  ---- ------------------ ------------------------------------------- --- ---------------------- ----------------------------------------- --------------------- ---
  1    Talc               Ovarian cancer                              ✘   Lung cancer            ✘                                          Breast cancer        ✘
  2    Methotrexate       Leukemia                                    ✔   Breast cancer          ✔                                         Lung cancer           ✔
  3    Thalidomide        Multiple myeloma                            ✔   Breast cancer          ▲                                         Prostate cancer       ▲
  4    Paclitaxel         Breast cancer                               ✔   Lung cancer            ✔                                         Ovarian cancer        ✔
  5    Prednisone         Multiple myeloma                            ▲   Non-Hodgkin lymphoma   ✔                                         Hodgkin's lymphoma    ✔
  6    Cisplatin          Lung cancer                                 ✔   Testicular cancer      ✔                                         Breast cancer         ✔
  7    Dexamethasone      Multiple myeloma                            ▲   Brain tumor            ✘[^a^](#t007fn002){ref-type="table-fn"}    Leukemia             ✔
  8    Doxorubicin        Leukemia                                    ✔   Hodgkin's lymphoma     ✔                                         Breast cancer         ✔
  9    Propranolol        Ovarian cancer                              ▲    Brain tumor           ✘                                          Colorectal cancer    ▲
  10   Interleukin 2      Melanoma                                    ✔    Leukemia              ▲                                          Hodgkin's lymphoma   ▲
  11   Cyclophosphamide   Leukemia                                    ✔   Multiple myeloma       ✔                                         Breast cancer         ✔
  12   Fluorouracil       Colorectal cancer                           ✔   Breast cancer          ✔                                         Stomach cancer        ✔
  13   Tamoxifen          Breast cancer                               ✔   Uterine cancer         ▲                                          Prostate cancer      ▲
  14   Vincristine        Leukemia                                    ✔   Hodgkin's lymphoma     ✔                                          Lung cancer          ✔
  15   Rituximab          Leukemia                                    ✔   Non-Hodgkin lymphoma   ✔                                          Multiple myeloma     ▲
  16   Bevacizumab        Breast cancer                               ✔   Colorectal cancer      ✔                                         Lung cancer           ✔
  17   HPV vaccines       Cervical cancer                             ✔   Breast cancer          ✘                                         Colorectal cancer     ✘
  18   Imatinib            Leukemia                                   ✔    Breast cancer         ▲                                          Prostate cancer      ▲
  19   Arsenic trioxide   Leukemia                                    ✔    Brain tumor           ▲                                          Breast cancer        ▲
  20   Dactinomycin       GTD[^b^](#t007fn003){ref-type="table-fn"}   ✔   Testicular cancer      ✔                                         Ovarian cancer        ✔

Notes:

^a^ Dexamethasone may be used to decrease swelling around the tumor.

^b^ Gestational trophoblastic disease.

It would be interesting to thoroughly study the most connected drugs and cancer types from the hidden contributions only, i.e., from $\left( G_{\text{qrnd}} \right)_{cr,d\text{or} d,cr}$ matrix elements only, in order to test the possible predictive power of the reduced Google matrix analysis of Wikipedia networks. This study is beyond the scope of the present work and will be considered in a subsequent one.

Conclusion {#sec013}
==========

Using PageRank and CheiRank algorithms, we investigate global influences of 37 cancer types and 203 cancer drugs through the prism of Human knowledge encoded in the English edition of Wikipedia considered as a complex network. From the ranking of Wikipedia articles using PageRank algorithm we extract the ranking of the most influent cancers according to Wikipedia. This ranking is in good agreement with rankings, by either mortality rates or yearly new cases, extracted from WHO GLOBOCAN 2018 \[[@pone.0222508.ref002]\] and Global Burden of Diseases study 2017 \[[@pone.0222508.ref005]\] databases.

The recently developed algorithm of the reduced Google matrix allows to construct a reduced network of cancers taking into account all the information aggregated in Wikipedia. This network exhibits direct and hidden links between the most influent cancers which form clusters of similar or related cancer types. The reduced Google matrix gives also countries or cancer drugs which are preferentially linked to the most influent cancers. Inferred relations between cancer types and countries obtained from Wikipedia network analysis are in accordance with global epidemiology literature. The PageRank sensitivity of countries to cancer types gives also a complementary tool corroborating epidemiological analysis. As far as we know, it is the first study highlighting correspondence between Wikipedia network analysis and disease burden or epidemiological studies. Inferred interactions between cancers and cancer drugs allows to determine drug prescriptions by Wikipedia for a specific cancer. These Wikipedia prescriptions appear to be compatible with approved medications reported in National Cancer Institute \[[@pone.0222508.ref025]\] and DrugBank \[[@pone.0222508.ref029]\] databases.

The reduced Google matrix algorithm allows to determine a clear and compact description of global influences and interactions of cancer types and cancer drugs integrating well documented medical aspects but also historical, and societal aspects, all encoded in the huge amount of knowledge aggregated in Wikipedia since 2001.
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